Azora Therapeutics, Inc. (DE) SEC filings ADIL
Azora Therapeutics, Inc. (DE) has 575 filings in SEC EDGAR's recent list, going back to Mar 16, 2011. Its latest annual report, Form ARS, was filed on Aug 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 16, 2026 | — |
| DEFA14A | Additional proxy material | Oct 5, 2026 | — |
| DEFA14A | Additional proxy material | Sep 18, 2026 | — |
| DEFA14A | Additional proxy material | Sep 16, 2026 | — |
| DEF 14A | Proxy statement | Aug 24, 2026 | Sep 17, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 11, 2026 | Aug 10, 2026 |
| DEF 14A | Proxy statement | Jan 6, 2026 | Feb 26, 2026 |
| PRE 14A | Preliminary proxy statement | Dec 23, 2025 | Dec 23, 2025 |
| DEF 14A | Proxy statement | Jun 10, 2025 | Jul 24, 2025 |
| PRE 14A | Preliminary proxy statement | May 23, 2025 | May 23, 2025 |
| DEF 14A | Proxy statement | Sep 27, 2024 | Nov 12, 2024 |
| DEFA14A | Additional proxy material | Dec 15, 2023 | — |
| DEF 14A | Proxy statement | Dec 8, 2023 | Jan 11, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 24, 2023 | Nov 24, 2023 |
| DEF 14A | Proxy statement | Oct 2, 2023 | Nov 2, 2023 |
| DEFA14A | Additional proxy material | Mar 29, 2023 | — |
| DEF 14A | Proxy statement | Mar 6, 2023 | Apr 12, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 24, 2023 | Feb 24, 2023 |
| DEF 14A | Proxy statement | Sep 1, 2022 | Oct 13, 2022 |
| DEF 14A | Proxy statement | Aug 23, 2021 | Sep 27, 2021 |
| DEFA14A | Additional proxy material | Jul 31, 2020 | — |
| DEF 14A | Proxy statement | Jul 21, 2020 | Sep 1, 2020 |
| DEF 14A | Proxy statement | Jul 8, 2019 | Aug 16, 2019 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AZR (Nasdaq), ADIL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Encino, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1513525
- Former names
- ADIAL PHARMACEUTICALS, INC. (until Oct 30, 2026); Adial Pharmaceuticals, L.L.C. (until Sep 28, 2017); ADial Pharmaceuticals, L.L.C. (until Sep 28, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.